Filter
1637
Filtered Results: 1637
Text search:
diagnóstico
molecular
Featured
Recommendations
190
New Publications
289
Language
Document type
No document type
707
Guidelines
402
Studies & Reports
272
Manuals
99
Strategic & Response Plan
79
Fact sheets
41
Training Material
16
Situation Updates
10
Resource Platforms
6
Infographics
4
Brochures
1
Countries / Regions
India
79
Latin America and the Carribbean
69
Western and Central Europe
54
Brazil
53
Global
52
Eastern Europe
35
Colombia
33
Africa
33
Kenya
25
Argentina
24
South Africa
22
Senegal
21
Peru
21
Tanzania
21
Ethiopia
19
El Salvador
17
West and Central Africa
17
Venezuela
16
Russia
16
Mozambique
15
Germany
15
East and Southern Africa
15
Paraguay
14
Congo, Democratic Republic of
13
Rwanda
11
Chile
11
Malawi
11
South–East Asia Region
11
Nigeria
10
Asia
10
Bolivia
10
Uganda
10
Sierra Leone
9
Cameroon
9
Philippines
9
Angola
9
Zambia
9
Ecuador
9
Ukraine
8
Burkina Faso
8
Liberia
8
Bangladesh
7
Ghana
6
Zimbabwe
6
Nepal
5
Benin
5
Guinea
5
Eastern Europe and Central Asia
5
Spain
5
Namibia
5
USA
4
Haiti
4
Middle East and North Africa
4
Western Pacific Region
4
North America
4
France
4
Côte d’Ivoire / Ivory Coast
4
Indonesia
4
Myanmar / Burma
4
Madagascar
4
Uruguay
3
Mali
3
Eswatini/ Swaziland
3
Pakistan
3
Guatemala
3
Mexico
2
Syria
2
Congo-Brazzaville
2
Niger
2
Italy
2
Cambodia
2
Dominican Republic
2
Guinea-Bissau
2
Lebanon
2
Georgia
2
Honduras
2
Chad
2
Tajikistan
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
Turkey
1
Gambia
1
Togo
1
China
1
Canada
1
Estonia
1
Burundi
1
Morocco
1
Mauritania
1
Jordan
1
Saudi Arabia
1
Luxembourg
1
Turkmenistan
1
Belgium
1
United Kingdom
1
Portugal
1
Nicaragua
1
Djibouti
1
Romania
1
Palestine
1
Central African Republic
1
Libya
1
Botswana
1
Iraq
1
Somalia
1
Cuba
1
Authors & Publishers
Publication Years
Category
Countries
579
Clinical Guidelines
214
Pharmacy & Technologies
66
Public Health
58
Key Resources
24
Women & Child Health
19
Capacity Building
5
Toolboxes
TB
391
COVID-19
256
NTDs
139
AMR
98
Rapid Response
79
HIV
78
Mental Health
65
Ebola & Marburg
43
Zika
29
Pharmacy
25
Planetary Health
24
NCDs
17
Refugee
15
Polio
14
Caregiver
11
Health Financing Toolbox
8
Cholera
7
Specific Hazards
5
Global Health Education
5
Natural Hazards
4
Disability
4
Malaria
4
Conflict
3
Through technical consultations with countries and partners, WHO has led the development of Preparedness and Resilience for Emerging Threats Module 1: Planning for respiratory pathogen pandemics. Version 1.0. The Module, currently available as an advanced draft, builds on previous pandemic lessons a...
The increasing global trend of Antimicrobial resistance (AMR) has gradually emerged as a major public health challenge for the entire world. AMR has spread to almost all countries and regions, including Pakistan owing to the “misuse and overuse” of Antimicrobials, contributing to the increasing ...
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л...
The objectives of NAP are aligned with the global action plan based on national needs and priorities. The emphasis is on One Health approach with all sectors especially human health, animal health and environment contributing towards minimizing the emergence and impact of AMR in Jordan.
Report of a WHO technical consultation meeting
Ouagadougou, Burkina Faso
J. European Academy of Dermatology and Venereology, 4 August 2014
14–22 April 2015
Introduction
Capter A.1
Ethics and international child and adolescent psychiatry
A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
AHA/ASA Guideline
DOI: 10.1161/STR.0000000000000158
The COVID-19 pandemic’s immediate costs, measured in lives lost and damaged, have been appalling and continue to rise. In addition, its effects on individuals’ livelihoods and economies around the world have been deep and are likely to be long lasting. While saving lives was the near-exclusive f...
This new plan has been developed to build on successes made and lessons learnt from implementation of the two initial plans and to provide a short to medium term strategic anchor against which preparedness and response plans to the corona virus disease COVID-19 epidemic in the country should focus o...
As of 12 December 2022, over 645 million people worldwide have been diagnosed with COVID-19, with over 6.6 million deaths (4).
The Omicron variant, which emerged in late November 2021, and its subvariants, are now the dominant circulating viruses, contributing to the ongoing surge in several countr...
The ICMR type 1 diabetes guidelines come at a time when the SARS-CoV-2 pandemic
has disproportionately affected people with diabetes population, exposing them to a
high risk for severe illness and mortality. Globally, diabetes was responsible for over fourmillion deaths in the year 2019. It was th...
The Lancet Regional Health Americas Volume 37100832 September 2024
Investing in and building longer-term health emergency preparedness during the COVID-19 pandemic
recommended
Interim Guidance
This document is to help Member States build on actions taken during the COVID-19 pandemic to improve national medium- to long-term preparedness for future threats. It maps COVID-19 preparedness and response actions to the building of sustainable International Health Regulations (2...
Mission report April 2016
4–15 February 2013
The use of safe and efficacious insecticides against the adult and larval populations of mosquito vectors is one of the most effective ways to rapidly interrupt transmission of Zika virus, as well as other viruses transmitted by Aedes mosquitoes such as chikungunya and dengue.
This report is primarily intended for the community of policymakers and researchers concerned about the rising risks of domestic, regional, and global infectious disease epidemics, and the collective failure to take the coordinated actions required to reduce such risks. These risks include the expec...
